Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pathology and Surgery of the Salivary GlandsR. A. Cawson, M. J. Gleeson, J. W. Eveson Isis Medical Media Ltd, 1997 ISBN 1 899066 61 6 Price: £130.00

Autor: Lesley A. Smallman

Publikováno v: The Journal of Laryngology & Otology. 112:694-694

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5bdeb86202f1281fa1d3ce69cad7daa4
https://doi.org/10.1017/s0022215100141490

Complications and Healthcare Costs Associated With the First Year Following Colostomy and Ileostomy Formation: A Retrospective Study.

Autor: Brady RRW; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Scott J; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Grieveson S; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Aibibula M; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Cawson M; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Marks T; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Page J; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Artignan A; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark., Boisen EB; Richard R. W. Brady, FRCSEd, MD, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Julia Scott, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Stephanie Grieveson, Newcastle Centre for Bowel Disease Research Group, Newcastle Hospitals and Newcastle University, Royal Victoria Hospital, Newcastle, United Kingdom.; Miriayi Aibibula, PhD, Coloplast Ltd, Peterborough, United Kingdom.; Matthew Cawson, MEnt, Coloplast Ltd, Peterborough, United Kingdom.; Tatjana Marks, MSc, Costello Medical Consulting Ltd, London, United Kingdom.; Jennifer Page, BSc, Costello Medical Consulting Ltd, Manchester, United Kingdom.; Audrey Artignan, MPhil, Costello Medical Consulting Ltd, Cambridge, United Kingdom.; Esben Bo Boisen, MSc, Coloplast A/S, Humlebaek, Denmark.

Publikováno v: Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society [J Wound Ostomy Continence Nurs] 2023 Nov-Dec 01; Vol. 50 (6), pp. 475-483.

Cost-effectiveness analysis of HIV pre-exposure prophylaxis in Japan.

Autor: Mizushima D; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan., Nagai Y; Gilead Sciences, Tokyo, Japan., Mezzio D; Gilead Sciences, Foster City, USA., Harada K; Gilead Sciences, Tokyo, Japan., Piao Y; Gilead Sciences, Tokyo, Japan., Barnieh L; Maple Health Group, New York (NY), USA., El Moustaid F; Maple Health Group, New York (NY), USA., Cawson M; Maple Health Group, New York (NY), USA., Taniguchi T; Chiba University Hospital, Chiba, Japan.

Publikováno v: Journal of medical economics [J Med Econ] 2023 Jan-Dec; Vol. 26 (1), pp. 886-893.

Examining the impact of haemophilia treatment on health-related quality of life.

Autor: Shaikh A; HCD Economics, Daresbury, UK., Pedra G; HCD Economics, Daresbury, UK., Cawson M; HCD Economics, Daresbury, UK., Wiseman C; Swedish Orphan Biovitrum Ltd., Cambridgeshire, UK.

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Sep; Vol. 28 (5), pp. 796-805. Date of Electronic Publication: 2022 May 10.